Patient Profile 3: A Patient with HER2+ Gastric Cancer Treated With T-DXd–who Develops Neutropenia

Video

Centering discussion on a patient profile of HER2+ gastric cancer, experts in oncology discuss the occurrence of neutropenia with trastuzumab deruxtecan therapy.

Recent Videos
woman with a white top sitting in front of a green wall
a man wearing a suit and tie in front of a green screen with the ONN logo
a woman sitting in front of a green wall with a white top and glasses
a woman with a white shirt and glasses sitting in front of a green wall.
Ann H. Partridge, MD, MPH, in an interview with Oncology Nursing News at 2024 ESMO Congress.
Pattie Jakel
Christine Wylie
Related Content
A simple dark blue line illustration of a pancreas on a light blue background

Telotristat Ethyl Plus Chemo May Stabilize Weight in Metastatic PDAC

Darlene Dobkowski, MA
January 28th 2025
Article

Managing weight loss with telotristat ethyl in patients with metastatic pancreatic ductal adenocarcinoma may improve survival, although further research is needed.

The Vitals

ctDNA Monitoring is a Piece of the Puzzle in CRC Treatment

Lindsay Fischer
October 31st 2023
Podcast

Holly Chitwood, DNP, FNP-C, AGACNP-BC, explains how circulating tumor DNA monitoring helps providers screen minimal residual disease in individuals with colorectal cancer.

Diagram of a person with gastrointestinal tract highlighted

Evorpacept Demonstrates Efficacy in HER2-Positive Gastric/GEJ Cancer

Roman Fabbricatore
January 27th 2025
Article

Phase 2 findings show clinical responses and improved survival with evorpacept in patients with HER2-positive gastric/gastroesophageal cancer.

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Lindsay Fischer
October 2nd 2023
Podcast

Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.

older woman sitting at a table with a glass of water

Baseline Geriatric Assessment and QOL Impact Chemotherapy Survival in Pancreatic Cancer

Roman Fabbricatore
January 25th 2025
Article

The EA2186 trial was the first study specifically designed to test chemotherapy in older adults with advanced pancreatic cancer who were considered vulnerable.

yellow background with a white outline indicating the pancreas

Liposomal Irinotecan, Oxaliplatin Dose Reduction May Not Affect Survival in Metastatic PDAC

Jax DiEugenio
January 25th 2025
Article

Analysis of the NAPOLI 3 trial showed that lower doses of liposomal irinotecan or oxaliplatin did not reduce survival in patients with pancreatic ductal adenocarcinoma.